GAIN THERAPEUTICS INC (GANX)
US36269B1052 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -22.27M | -17.59M | -13.89M | -3.58M | -2.19M | |||
| Depreciation Amortization | 83.58K | 60.00K | 20.00K | 10.00K | 0.00 | |||
| Change In Working Capital | 442.23K | 1.51M | -390.00K | 240.00K | 310.00K | |||
| Taxes Paid | 134.96K | 0.00 | N/A | 0.00 | 10.00K | |||
| Other non cash items | 2.88M | 1.32M | 1.89M | 90.00K | 10.00K | |||
| OPERATING CASH FLOW | -18.87M | -14.69M | -12.37M | -3.24M | -1.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -15.36K | -120.00K | -90.00K | -20.00K | -10.00K | |||
| Other Investing Activity | 10.24M | -14.66M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 10.22M | -14.77M | -90.00K | -20.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -89.07K | -80.00K | -20.00K | 740.00K | 0.00 | |||
| Stock Issued/Repurchased | 12.73M | 0.00 | 42.64M | 10.22M | 1.75M | |||
| Other Financing Activity | N/A | 0.00 | -850.00K | -470.00K | 0.00 | |||
| FINANCING CASH FLOW | 12.64M | -80.00K | 41.77M | 10.49M | 1.75M | |||
| Exchange Rate Effect | 488.40K | -20.00K | 100.00K | -40.00K | 30.00K | |||
| CHANGE IN CASH | 4.49M | -29.56M | 29.41M | 7.19M | -100.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.87M | -14.69M | -12.37M | -3.24M | -1.87M | |||
| Capital Expenditure | -15.36K | -120.00K | -90.00K | -20.00K | -10.00K | |||
| FREE CASH FLOW | -18.88M | -14.81M | -12.46M | -3.26M | -1.88M | |||
All data in USD